TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Asahi Kasei ( (JP:3407) ) has provided an announcement.
Asahi Kasei Corporation reported an increase in operating income for the first quarter of fiscal 2025, driven by significant growth in its healthcare segment, particularly pharmaceuticals, and strong performance in domestic housing. However, the company experienced a decrease in net income due to losses from discontinuing its MMA business in the materials segment. Despite this, the company has revised its operating and net income forecasts upward for the first half of 2025, with expectations of improved extraordinary income/loss in the second quarter.
The most recent analyst rating on (JP:3407) stock is a Hold with a Yen1140.00 price target. To see the full list of analyst forecasts on Asahi Kasei stock, see the JP:3407 Stock Forecast page.
More about Asahi Kasei
Asahi Kasei Corporation operates in the chemical industry, providing a diverse range of products and services including materials, healthcare, and homes. The company focuses on essential chemicals, pharmaceuticals, and domestic housing, positioning itself as a key player in these markets.
Average Trading Volume: 4,527,100
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen1409.6B
Find detailed analytics on 3407 stock on TipRanks’ Stock Analysis page.